Fabtech Technologies
add_icon

Fabtech Technologies

162.80
-6.58
(-3.88%)
Market Cap
723.66 Cr
PE Ratio
19.62
Volume
4,67,815.00
Day High - Low
170.70 - 162.10
52W High-Low
262.80 - 132.70
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
723.66 Cr
EPS
10.00
PE Ratio
19.62
PB Ratio
1.79
Book Value
94.43
EBITDA
35.00
Dividend Yield
0.35 %
Industry
Healthcare
Return on Equity
26.83
Debt to Equity
0.32
Forecast For
Actual

Company News

View All News
Caret
positive
Fabtech Technologies Limited achieved total income of ₹431.33 crore in FY26, up 28.4% YoY, with EBITDA rising 18.29% to ₹55.56 crore despite global challenges.
positive
Management expects 25-30% order book growth, maintains FY27 revenue targets of ₹530-600 crores, and projects FY28 PAT margins of 12-14% with improved operational metrics.
neutral
Fabtech Technologies Limited submitted its quarterly certificate under SEBI regulations for Q4FY26, confirming all shares remain in demat form with no rematerialisation requests received during the quarter.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,671.10
#1 16,938.18
48.11
#1 1,759.00
22.62
#1 339
-16.90
70.51
214.70
1,142.34
57.81
408.40
32.64
30
-5.66
52.60
204.03
1,121.39
51.17
242.40
24.12
25
-58.33
53.03
522.45
924.45
47.68
186.60
40.62
20
-
41.11
162.80
#5 723.66
#1 19.62
#2 410.77
#7 22.29
#2 36
#2 46.36
53.09
402.75
698.24
55.35
251.30
45.01
17
-67.50
47.92
420.00
504.10
25.00
67.10
13.15
18
4.44
48.47
380.00
495.43
58.64
111.80
-
8
-
76.89
207.55
395.18
27.74
136.30
#1 107.77
16
-
41.82
271.75
259.30
25.78
122.10
19.24
1
#1 232.14
52.09

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
22.29 %
Net Income Growth
-21.53 %
Cash Flow Change
-159.80 %
ROE
29.99 %
ROCE
10.88 %
EBITDA Margin (Avg.)
-42.27 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
49
61
106
138
71
125
70
168
Expenses
37
54
81
117
74
91
74
136
EBITDA
12
7
25
22
-4
34
-5
32
Operating Profit %
-28 %
8 %
22 %
14 %
-9 %
25 %
-18 %
14 %
Depreciation
1
1
1
1
1
1
1
1
Interest
0
0
0
1
1
1
1
1
Profit Before Tax
11
6
24
20
-6
31
-7
30
Tax
5
1
3
5
-0
3
-1
8
Net Profit
6
5
21
15
-6
28
-6
22
EPS in ₹
1.79
1.58
6.32
4.66
-1.89
8.68
-1.56
5.75

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
2026
Total Assets
124
126
172
214
269
427
654
Fixed Assets
2
2
5
4
22
94
55
Current Assets
110
114
147
181
241
314
516
Capital Work in Progress
0
0
0
0
0
0
0
Investments
7
2
17
20
21
15
21
Other Assets
114
122
150
190
226
318
6
Total Equity & Liabilities
124
126
172
214
269
427
654
Current Liabilities
83
77
101
122
135
226
207
Non Current Liabilities
2
2
4
3
3
28
27
Total Equity
38
46
67
89
132
173
420
Reserve & Surplus
38
46
65
86
129
141
375
Share Capital
0
0
3
3
3
32
45

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
19
-20
Investing Activities
-30
-20
Operating Activities
60
-36
Financing Activities
-12
36

Share Holding

% Holding
Sept 2024
Sept 2025
Oct 2025
Dec 2025
Mar 2026
Promoter
94.61 %
68.94 %
68.94 %
68.94 %
68.94 %
FIIs
0.00 %
1.91 %
1.91 %
0.03 %
0.08 %
DIIs
0.00 %
11.63 %
11.63 %
1.99 %
2.15 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
16.09 %
16.09 %
22.25 %
21.71 %
Others
5.39 %
1.43 %
1.43 %
6.79 %
7.12 %
No of Share Holders
31
31
34
31,755
28,620

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
27 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Oct 2025 182.95 207.55
02 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 Feb 2026 160.55 163.50
27 Apr 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Apr 2026 156.35 154.80

Announcements

Announcement under Regulation 30 (LODR)-Monitoring Agency Report5 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptApr 30, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeApr 28, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationApr 28, 2026
Intimation Of Statement Of Deviation Or Variation In Utilization Of Funds For The Quarter Ended March 31 2026 Raised Through Initial Public Issue ("IPO")Apr 27, 2026
Corporate Action-Board approves DividendApr 27, 2026
Board Meeting Outcome for Outcome Of Board Meeting Scheduled On April 27 2026Apr 27, 2026
Outcome Of Board Meeting For Audited Financial Results For FY 2025-26Apr 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 23, 2026
Board Meeting Intimation for Audited Financial Results And Dividend For Period Ended March 31 2026.Apr 22, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Announcement On Order Booking And Business UpdatesApr 04, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 27, 2026
Closure of Trading WindowMar 26, 2026
Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held Today I.E. March 24 2026.Mar 24, 2026
Outcome Of Analysts/ Investors Meetings Held On March 10 2026Mar 11, 2026
Reply To The Clarification Sought By National Stock Exchange Of India Limited On Movement In Price Of The Shares Across Exchanges Of Shares Of The Company.Mar 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 14, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 10, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 10, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 04, 2026
Statement Of Nil Deviation Or Variation As Per Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended December 31 2025Feb 02, 2026
Unaudited Financial Results Of Quarter And Nine-Month Ended December 31 2025Feb 02, 2026
Board Meeting Outcome for Intimation Of Outcome Of Board Meeting.Feb 02, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Board Meeting Intimation for Intimation Of The Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 28, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Closure of Trading WindowDec 29, 2025
Outcome Of Analysts / Investors Meeting Held On December 26 2025Dec 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 18, 2025
Outcome Of Analysts / Investors Meeting Held On December 10 2025Dec 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 18, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 14, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 10, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 06, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 04, 2025
Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half-Year Ended September 30 2025Nov 04, 2025
Unaudited Standalone And Consolidated Financials Results Of The Company For The Quarter Ended June 30 2025Nov 04, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.01%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
61.13
ATR(14)
Volatile
8.67
STOCH(9,6)
Neutral
38.69
STOCH RSI(14)
Neutral
37.32
MACD(12,26)
Bullish
0.21
ADX(14)
Strong Trend
40.20
UO(9)
Bearish
39.19
ROC(12)
Uptrend And Accelerating
8.23
WillR(14)
Neutral
-45.09